Trials / Terminated
TerminatedNCT00418873
Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward
A Multi-centre Comparative Study to Evaluate the Anti-aggression Effect and Safety of Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the efficacy and tolerability of zotepine versus Risperidone in aggressive schizophrenic patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Zotepine | Oral |
| DRUG | Risperidone | Oral |
Timeline
- Start date
- 2007-03-01
- Primary completion
- 2009-12-01
- Completion
- 2009-12-01
- First posted
- 2007-01-05
- Last updated
- 2010-04-16
Locations
4 sites across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT00418873. Inclusion in this directory is not an endorsement.